Cryptorchidism

Comprehensive Clinical Guide: Cryptorchidism (Undescended Testis)

1. Comprehensive Introduction & Overview

Cryptorchidism, derived from the Greek kryptos (hidden) and orchis (testis), is the most common congenital anomaly of the genitourinary tract in male infants. It is defined as the failure of one or both testes to descend into the scrotum during the developmental process. While the majority of cases are identified at birth, the condition remains a significant clinical concern due to its strong correlation with impaired spermatogenesis, subfertility, and an increased risk of testicular malignancy.

In a normal physiological state, the testes descend from the posterior abdominal wall through the inguinal canal into the scrotal sac. This process is typically completed by the 35th week of gestation. Failure of this migration results in an undescended testis, which may be located anywhere along the normal path of descent or, in cases of ectopic testes, outside this path entirely.

2. Deep-Dive: Etiology and Pathophysiology

Etiology

The precise cause of cryptorchidism is multifactorial, involving a complex interplay between hormonal, genetic, and environmental factors.

• Hormonal Factors: The "two-step" theory of testicular descent is widely accepted. The first phase (transabdominal) is regulated by Insulin-like factor 3 (INSL3). The second phase (inguinoscrotal) is androgen-dependent, requiring testosterone and dihydrotestosterone.
• Genetic Factors: Mutations in the INSL3 gene or its receptor RXFP2 are implicated in a subset of cases. Furthermore, cryptorchidism is a feature of several genetic syndromes, including Prader-Willi, Noonan, and Klinefelter syndromes.
• Environmental Factors: Maternal exposure to endocrine-disrupting chemicals (e.g., phthalates, pesticides) and low birth weight/prematurity are significant risk factors.

Pathophysiology

The scrotum acts as a thermoregulatory organ, maintaining the testes at approximately 2–3°C below core body temperature. When a testis remains in an undescended position (intra-abdominal or inguinal), it is exposed to higher temperatures, which triggers:
1. Germ Cell Apoptosis: Early onset of programmed cell death in gonocytes.
2. Histological Alterations: Reduction in the number of spermatogonia and Leydig cells.
3. Tubular Atrophy: Progressive fibrosis of the seminiferous tubules, leading to irreversible parenchymal damage if left uncorrected.

3. Clinical Staging and Presentation

Classification of Testicular Position

Clinicians categorize cryptorchidism based on the anatomical location of the testis:

Clinical Presentation

Most cases are diagnosed during routine newborn screening. The physical exam should be performed in a warm environment with the patient in a "frog-leg" position to minimize cremasteric reflex. The absence of a testis in the scrotum is the primary indicator.

4. Diagnostic Workup and Differential Diagnosis

Key Diagnostic Tests

1. Physical Examination: The gold standard. If the testis is palpable, it is likely inguinal.
2. Imaging: Generally, imaging is not recommended for non-palpable testes because of low sensitivity and specificity. Ultrasound may be used for palpable testes, but it rarely changes the surgical management.
3. Laparoscopy: The definitive diagnostic tool for non-palpable testes. It allows for the visualization of the internal inguinal ring and the potential identification of vanishing testes (atrophic remnants).
4. Hormonal Evaluation: In cases of bilateral non-palpable testes, clinicians may measure serum LH, FSH, and testosterone, or perform an hCG stimulation test to assess the presence of functional testicular tissue.

Differential Diagnosis

• Retractile Testis: A common mimic. These testes are descended but "hide" due to the cremasteric reflex. They do not require surgery, only monitoring.
• Anorchia: Congenital absence of the testis.
• Testicular Torsion: An acute surgical emergency that must be ruled out if the undescended testis presents with sudden pain.

5. Clinical Management and Surgical Indications

The surgical standard of care is Orchidopexy.

• Timing: Current guidelines (AUA/ESPU) recommend surgery between 6 and 18 months of age. Early intervention is critical to preserve long-term fertility and reduce the risk of malignancy.
• Surgical Approach:
  • Inguinal Orchidopexy: For palpable testes, an inguinal incision is made to mobilize the spermatic cord and fix the testis in a sub-dartos pouch in the scrotum.
  • Laparoscopic Orchidopexy: For non-palpable testes. If the testis is located high in the abdomen, a two-stage Fowler-Stephens procedure may be required to preserve the blood supply.

6. Risks, Side Effects, and Long-Term Prognosis

Risks of Untreated Cryptorchidism

1. Infertility: Bilateral undescended testes have a significantly higher risk of azoospermia or severe oligospermia.
2. Malignancy: Patients with a history of cryptorchidism have a 3- to 5-fold increased risk of developing testicular germ cell tumors. Notably, orchidopexy does not eliminate this risk but makes the testis accessible for self-examination and monitoring.
3. Testicular Torsion: An undescended testis is more prone to torsion due to poor gubernacular attachment.
4. Psychosocial Impact: Empty scrotum syndrome can lead to body image issues in adolescence.

Complications of Surgery

• Testicular Atrophy: Occurs in <5% of cases due to vascular injury during dissection.
• Hematoma/Infection: Standard risks associated with any surgical procedure.
• Recurrence: The testis may retract if the spermatic cord is not sufficiently mobilized.

7. Massive FAQ Section

1. Is a retractile testis the same as cryptorchidism?
No. A retractile testis is a normal variant where the testis is intermittently pulled into the canal by a strong muscle reflex. It usually descends on its own during puberty and does not require surgery.

2. At what age should surgery be performed?
Surgery is recommended between 6 and 18 months. Waiting beyond 18 months may lead to permanent histological changes in the seminiferous tubules.

3. Does surgery eliminate the risk of cancer?
No, it does not. However, it allows the testis to be placed in the scrotum, making it possible for the patient to perform regular self-exams to detect lumps or changes.

4. What happens if the testis is "non-palpable"?
Laparoscopy is the gold standard for non-palpable testes. It allows the surgeon to see if the testis is in the abdomen or if it is "absent" (vanishing testis).

5. Are there hormonal treatments for cryptorchidism?
Hormonal therapy (e.g., hCG or GnRH analogues) is sometimes used in Europe, but it has low success rates and is not recommended by the American Urological Association.

6. Can a testis descend on its own after birth?
Spontaneous descent can occur in premature infants during the first 3–6 months of life. After 6 months, spontaneous descent is extremely rare.

7. What is an "ectopic" testis?
An ectopic testis has deviated from the standard pathway and may be found in the perineum, femoral canal, or even at the base of the penis. These require surgical correction.

8. Will my child be infertile?
Fertility outcomes depend on the duration of the undescended state and whether the condition was unilateral or bilateral. Early surgery significantly improves the chances of normal spermatogenesis.

9. Is an ultrasound necessary before surgery?
Generally, no. Ultrasound has a low sensitivity for non-palpable testes and may lead to unnecessary delays or misleading information. Physical exam under anesthesia is more reliable.

10. What is the "Fowler-Stephens" procedure?
This is a specialized two-stage surgery for high intra-abdominal testes. It involves clipping the main testicular artery to allow the testis to receive blood supply from the vas deferens, then moving it to the scrotum in a second stage.

8. Conclusion for Clinicians

Cryptorchidism is a manageable condition, but timing is the most critical variable for patient outcomes. As clinical specialists, the focus must remain on early detection, avoiding over-reliance on imaging, and timely referral to a pediatric urologist. By adhering to the 6–18 month surgical window, we maximize the potential for long-term fertility and facilitate better monitoring for potential malignancies, ultimately improving the patient's quality of life.